Redpoint Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.12M Sell
4,187
-47
-1% -$9.98K 0.16% 152
2022
Q2
$863K Hold
4,234
0.1% 243
2022
Q1
$892K Hold
4,234
0.09% 267
2021
Q4
$1.02M Sell
4,234
-67
-2% -$17.2K 0.08% 286
2021
Q3
$1.22M Sell
4,301
-103
-2% -$33.8K 0.1% 229
2021
Q2
$1.52M Sell
4,404
-85
-2% -$25.8K 0.12% 199
2021
Q1
$1.26M Hold
4,489
0.11% 220
2020
Q4
$1.1M Sell
4,489
-377
-8% -$97.3K 0.11% 202
2020
Q3
$1.38M Sell
4,866
-9,475
-66% -$2.64M 0.15% 163
2020
Q2
$3.84M Sell
14,341
-1,870
-12% -$562K 0.21% 107
2020
Q1
$5.13M Sell
16,211
-7,679
-32% -$2.33M 0.32% 73
2019
Q4
$7.09M Sell
23,890
-1,026
-4% -$285K 0.35% 63
2019
Q3
$5.8M Buy
24,916
+3,083
+14% +$718K 0.31% 74
2019
Q2
$5.11M Buy
21,833
+3,041
+16% +$702K 0.27% 87
2019
Q1
$4.44M Buy
18,792
+2,169
+13% +$683K 0.22% 110
2018
Q4
$5M Sell
16,623
-3,486
-17% -$1.11M 0.29% 77
2018
Q3
$7.11M Sell
20,109
-530
-3% -$182K 0.36% 66
2018
Q2
$5.99M Sell
20,639
-165
-0.8% -$46.4K 0.33% 74
2018
Q1
$5.7M Buy
20,804
+273
+1% +$84.7K 0.32% 74
2017
Q4
$6.54M Buy
+20,531
New +$6.59M 0.36% 59

Other funds holding BIIB

Redpoint Investment Management's BIIB Position: Q3 2022 in Review

Redpoint Investment Management reduced its Biogen (BIIB) stake by 1.1% in Q3 2022, selling an estimated $9.98K and leaving 4,187 shares worth $1.12M. The position accounts for 0.16% of the portfolio, ranked #152.

Redpoint Investment Management first reported a position in BIIB in Q4 2017 and has held it in 20 quarters since. The position peaked at $7.11M in Q3 2018. 986 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • Redpoint Investment Management held 4,187 shares of Biogen worth $1.12M as of Q3 2022.
  • Redpoint Investment Management sold 47 Biogen shares in Q3 2022, an estimated $9.98K.
  • Biogen made up 0.16% of Redpoint Investment Management's portfolio in Q3 2022, its #152 holding.
  • Redpoint Investment Management first reported a position in Biogen in Q4 2017 and has held it in 20 quarters since.
  • Redpoint Investment Management's Biogen position peaked at $7.11M in Q3 2018.
  • 986 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.